<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97-marinedrugs-17-00374" class="ref">
 <label class="label">97.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Shen</surname>
    <given-names class="given-names">X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Shi</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zhang</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Li</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zhao</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zhang</surname>
    <given-names class="given-names">R.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohnâ€™s disease and ulcerative colitis: A meta-analysis</article-title>
  <source class="source">Digestion</source>
  <year class="year">2010</year>
  <volume class="volume">81</volume>
  <fpage class="fpage">69</fpage>
  <lpage class="lpage">77</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1159/000260417</pub-id>
  <?supplied-pmid 20093834?>
  <pub-id pub-id-type="pmid" class="pub-id">20093834</pub-id>
 </element-citation>
</ref>
